2012 Exhibitor List
Exhibitor List As Of February 03, 2012
Special Rate for Pharmaceutical & Small Molecule Biotech R&D Only Companies with Phase I-III compounds. Click "Register" Above for Details
Adesis [ company website ] |
|
 |
Adesis Inc., a Delaware-based company, offers a range of chemistry services for early-stage to the leading life sciences companies. We provide support for early proof-of-concept projects, medicinal chemistry, lead optimization, custom syntheses and process development. We also specialize in the chemistry of orthogonally functionalized azaheterocycles (pyridines, azaindoles, piperidines and pyrrolidines). We aim to create value for our clients. |
Aesica Pharmaceuticals [ company website ] |
|
 |
Aesica Pharmaceuticals is an innovative and service driven supplier of APIs, finished dosage forms and custom synthesis solutions to the global pharmaceutical and biotechnology industries. Aesica delivers products from the early-phase clinical development stage right through to commercial supply. Aesica also has the facilities for manufacturing high potency drugs and controlled substances. |
Albemarle Corporation [ company website ] |
|
 |
Albemarle Corporation is a leading global developer, manufacturer, and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. The Company is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry. |
AllessaSyntec [ company website ] |
|
 |
The core business of the AllessaSyntec GmbH & Co. KG is the rapid scale-up of sophisticated chemical products from a laboratory process to industrial quantities and the custom synthesis of pharmaceutical non-GMP intermediates from 10's of kilograms up to 50 tons per year. AllessaSyntec developed a strong expertise in low-temperature reactions down to -100 °C for the synthesis of boronic acids and specialty aldehydes in vessels with a capacity of up to 1000 liters. Other core competencies are high pressure reactions like carbonylations, specialty hydrogenations, and air oxidations up to 200 bar in vessels with a volume of up to 1800 liters. You are welcome to visit us at booth 79 and to attend our Capability Presentation "Advance by Technology: High-Pressure and Low-Temperature Syntheses on Industrial Scale" on Tuesday, September 13 at 4:30 p.m. in Track room A! For arranging a meeting during the conference, please contact by e-mail: RAmitrano@RAAAssociates.com |
Almac Group [ company website ] |
|
 |
Almac Group provides world-class, integrated solutions to the global pharmaceutical and biotechnology industries. Our services include process R&D, custom synthesis of API; micronization, 14C radio-labeling, formulation and analytical development; commercial-scale manufacture; packaging; storage; QP release; supply chain management; diagnostic/genomic services, preparation of clinical supplies and technology solutions (IVRS /Web/EDC). |
Alphora Research [ company website ] |
|
 |
Alphora Research Inc. provides API technology development services for the scale up of complex small molecules with pharmaceutical applications. Alphora's services include process development, analytical development and validation, stability testing and cGMP synthesis. Alphora's 40,000 sq.ft. facility includes cGMP Kilo Labs and Pilot Plant operations and supporting organic and analytical laboratories. |
AMRI [ company website ] |
|
 |
AMRI is uniquely positioned in the marketplace to provide a competitive advantage to a diverse group of customers. Our reputation of providing the highest quality service and a variety of pricing options provides more companies with the security of sourcing discovery, development, small and large scale manufacturing projects throughout our global network of research and manufacturing facilities. |
Apeloa Kangyu [ company website ] |
|
 |
Apeloa Kangyu is a reputed pharmaceutical company in China, engaging in R&D, manufacturing and marketing of APIs, key intermediates and formulations. It also has outstanding resources and rich experience for customer services. Apeloa Kangyu owns two GMP certified and US FDA approved facilities, and has passed OHSAS18001, ISO14001 and ISO9001 certifications. Its major APIs include Amantadine Series, Ofloxacin, Levofloxacin, Ephedrine, Pseudoephedrine, Colistin Sulfate, Tylosin, etc. |
Archimica [ company website ] |
|
 |
Archimica is a privately held pharmaceutical fine chemical company with 550 employees at six facilities in the US and Western Europe. The company has an excellent track record of regulatory compliance. Archimica has a long and successful history of commercialization of a wide range of technologies, including: enzymatic, organometallic, heterocyclic, nucleoside, asymmetric synthesis, hydrogenations and hazardous chemistries. Special technologies include bulk sterile production via aseptic filtration and production of DEA controlled substances. |
Ash Stevens [ company website ] |
|
 |
Ash Stevens is an established pharmaceutical contractor that develops, registers, and manufactures Active Pharmaceutical Ingredients (APIs). Founded in 1962, Ash Stevens has a long and successful history of delivering APIs on time and on budget. Behind our success is an experienced team of talented scientists and regulatory experts committed to providing the highest quality of service. Ash Stevens offers a comprehensive and flexible package of manufacturing services to support early-stage development, FDA registration, and commercialization. |
BASF [ company website ] |
|
 |
BASF offers a broad range of highly innovative inorganic specialties for the pharmaceutical industry. In addition to organozinc halide reagents, boranes and hydroxylamine, the extensive portfolio also comprises alkali metals as well as specialty alcoholates, other strong bases and hydroxyacetophenones. In cooperation from lab to launch, BASF brings innovations to its customers that create a competitive and sustainable advantage for them. Optimal conditions for this close collaboration are assured by BASF’s experienced and globally present team. |
BoroPharm |
|
 |
BoroPharm Inc. was formed to develop & market chemical building blocks to organizations who utilize boron containing intermediates to produce marketable products with unique and functional characteristics.BoroPharm offers customers access to an existing library of heteroaromatic boronic esters and offers custom synthesis solutions for clients seeking novel boron containing compounds. |
C&EN [ company website ] |
|
 |
C&EN is the largest weekly newsmagazine serving the chemical and life sciences industry for over 85 years. Each week, C&EN reports on the latest business and science news of interest to more than 161,000 readers representing executive managers, scientists, and those involved in R&D in the top labs in the U.S. and around the world. C&EN is the global advertising leader and publishes more than 40 special reports on pharmaceutical outsourcing, biopharmaceuticals, and pharmaceutical partnering to name a few. C&EN offers companies electronic advertising opportunities including co-branded Webinars, contextual & interstitial advertising, and high visibility online advertising |
Cambridge Major Laboratories [ company website ] |
|
 |
Cambridge Major Laboratories is a leading global chemistry outsourcing partner to the pharmaceutical and biotechnology industries, producing pharmaceutical intermediates and Active Pharmaceutical Ingredients. The Company has experienced explosive growth the past decade, and boasts a long, successful FDA inspection history. CML operates from three facilities in the US and Europe. |
Carbogen Amcis [ company website ] |
|
 |
CARBOGEN AMCIS AG combines world-class chemistry skills to provide seamless drug substance development and commercialization services for leading pharmaceutical and biotechnology companies. Through our customised offering we provide an array of integrated services operated in a fully cGMP compliant infrastructure, including a dedicated High Potency Facility. These services supports faster, safer drug development with improved cost efficiency, helping our clients make decisions more quickly and progress more candidates through the pipeline in a shorter period of time. |
Charnwood Molecular [ company website ] |
|
 |
Charnwood Molecular is a leading provider of synthetic chemistry services. Founded in 1998 and based in the UK, the company provides external synthetic chemistry support for the pharmaceutical, biotechnology, agrochemical and fine chemicals industries. The company offers custom synthesis and contract research services, undertaking projects tailored to the specific requirements of the client, delivered by experienced postdoctoral chemists working in fully equipped modern laboratories.
Charnwood Molecular’s portfolio of services is wide, and includes support for drug discovery research (library design, modelling, synthesis and optimisation), preparing key intermediates and multi gram scale-up. Collective chemistry experience is wide-ranging, but particular expertise exists in heterocyclic chemistry, medicinal chemistry; asymmetric synthesis and catalysis, and polymer supported organic synthesis. |
Chemetall GmbH [ company website ] |
|
 |
Chemetall is a global company committed to specialty chemistry. The Lithium Division of Chemetall is the world’s leading supplier of Lithium compounds. Following to our expertise in this field of chemistry we also supply other organometallic compounds such as Grignard reagents, Amides and Alkoxides. The company's product portfolio is based on continuous research and development of leading edge technologies. Headquartered in Germany, the Lithium Division serves its customers with a worldwide network of sales offices as well as with production sites in Germany, both South and North America and Taiwan. Since 2004, Chemetall has been part of Rockwood Holdings, Inc. |
Chemical Transfer Partnership [ company website ] |
|
-4900.jpg) |
Chemical Transfer Partnership (CTP) is the distributor of Chemical Processing equipment manufactured by Buchi AG for the Pharmaceutical and fine chemical industries in the US and Canada. We can supply a full range of equipment from small laboratory scale, up to pilot plant. The Buchi equipment can be easily configured for any process. We can offer many custom designs without sacrificing quality for delivery. We also are the proud representatives of Huber AG and Genser Rotary Evaporators. |
Chemistry Today [ company website ] |
|
 |
Fine chemicals, pharma chemistry, biotechnology: these are the main topics of Chimica Oggi/Chemistry Today specially addressed to a readership belonging to the industrial field. Funded in 1983 and considered one of the most credited journals in its sector, it boasts an ever increasing circulation worldwide, thanks to its highly scientific articles suitable for industrial applications. Chimica Oggi/Chemistry Today is essential to those who are looking for updated, accurate, reliable information; specially for those making the word “innovation” the keyword to their own mission. Every issue includes one or more monographic inserts entirely devoted to one specific subject. These inserts are being more and more appreciated by our readers as they can find in their pages a precious help to their constant commitment to the research and development field. |
Chiral Technologies, Inc. [ company website ] |
|
 |
Chiral Technologies, Inc. (CTI) is the market leader in the area of enantioselective chromatography. Together with Daicel Chemical Industries, we support all stages of the single-enantiomer drug development process from preclinical studies to commercial drug development. We offer a full range of chiral HPLC and SFC chromatography columns for analytical, semi-preparative and preparative separations. To accelerate drug development efforts, we provide the enantioselective resolution of quantities ranging from 200 milligrams to 200 kilograms of chiral compounds, under cGMP if required. We also provide process development and pilot studies for the manufacture of chiral intermediates of approved drugs. |
CU Chemie Uetikon GmbH [ company website ] |
|
 |
CU Chemie Uetikon GmbH is an established European Chemical and Pharmaceutical Producer and member of the Swiss CPH chemie+papier holding ag. Uetikon offers an extensive expertise to its pharmaceutical and biotechnology partners including:
Today, we have built a solid track record, by offering a high level of quality compliance in accordance to cGMP including a 20 year history of successful FDA inspections and state-of-the-art production facilities. |
Delmar Chemicals, Inc. [ company website ] |
|
 |
Delmar specializes in process development and custom cGMP synthesis of APIs and advanced intermediates. Delmar has well-equipped Process R&D and Analytical R&D laboratories, a cGMP pilot plant and a cGMP commercial-scale production facility. In addition, Delmar offers a full range of custom development and manufacturing services including process development and validation, analytical method development and validation, ICH stability studies and comprehensive regulatory support including the preparation of CMC sections and Drug Master Files. |
Digital Specialty Chemicals [ company website ] |
|
 |
Digital Specialty Chemicals is a private fine-chemical manufacturer, specializing in organophosphorus and organometallic chemistry. Since 1987, we have supplied custom and stock chemicals to pharmaceutical, semiconductor and specialty chemical markets worldwide. |
DIVERCHIM [ company website ] |
|
 |
DIVERCHIM is a privately owned company engaged in innovative chemistry based drug (and materials) discovery and development. We offer a broad range of integrated organic chemistry R&D capabilities and our proprietary technologies to pharmaceutical, biotechnology, agrochemical, and cosmetic companies. DIVERCHIM is committed to carrying out the customer's confidential contract research on a fee for service basis without downstream royalty payments. We assure complete confidentiality and technology transfer in the case of exclusive methodology development. Since January 2000, Diverchim has conducted R&D projects in collaboration with more than 20 pharmaceutical and biotechnology companies throughout the EC. Our Strengths include the highest scientific and quality standards, strong emphasis on customer service, excellent scientific staff and technology capabilities. |
Dottikon Exclusive Synthesis [ company website ] |
|
 |
DOTTIKON EXCLUSIVE SYNTHESIS is specialized on hazardous chemistry, with a focus on strongly exothermic reactions as well as unstable, highly reactive, or high-potent compounds or mixtures. DOTTIKON ES manufactures high-quality intermediates and exclusive APIs, from the kilogram to the multi-ton range, for the world's leading pharmaceutical and chemical industries. Hazardous reactions often allow to shorten production and synthesic procedures, reduce waste, improve yields, selectivity, and purity, and therefore reduce overall costs. Among the core strengths of DOTTIKON ES are: hazardous reactions, such as reductions with complex hydrides, alkylations, azide chemistry, nitrations and oxidations. As well as heterogeneous and homogeneous catalytic hydrogenations, continuous reaction technologies and low temperature reactions. |
ecovatal [ company website ] |
|
 |
evocatal is a German provider of enzyme technology and biocatalytical processes. The company offers a catalog of ready-to-use enzymes (evozymes) and chiral building blocks but also offers the customized development of exclusive biocatalysts and chemical processes, tailored to match the unique demands of our customers. evozymes are applied in API- and intermediate synthesis, but also in consumer goods industries, including the production and refinement of textiles, adhesives, detergents, nutrition and cosmetics. Our enzymes and chiral building blocks can be provided in every scale. |
Euticals [ company website ] |
|
 |
Euticals is a privately held pharmaceutical fine chemical manufacturer. We manufacture APIs in a broad range of therapeutic classes at 11 sites in the US and western Europe; 10 of these sites are cGMP. The chemical technology portfolio includes: organometallic chemistry, fermentation, bulk sterile production, nucleotides, peptides, HAPIs and cytotoxics. Consider Euticals, with our broad range of capabilities and expertise, to assist in your next outsourcing challenge. |
Evonik [ company website ] |
|
 |
Evonik’s Exclusive Synthesis & Amino Acids Business Line focuses on the customized production of pharmaceutical intermediates, active pharmaceutical ingredients (API'S) and high potency API's, amino acids, and high-quality derivatives. The global production and research network of the business line offers a seamless service portfolio, ranging from the development of synthesis on the laboratory scale to commercial production in U.S. Food and Drug Administration (FDA)-certified facilities. |
Evotec [ company website ] |
|
 |
Evotec is a leader in the discovery and development of novel small molecule drugs. The Company has built substantial drug discovery expertise and an industrialized platform that can drive new innovative small molecule compounds into the clinic. In addition, Evotec has built a deep internal knowledge base in the treatment of diseases related to neuroscience, pain, and inflammation. Leveraging these skills and expertise the Company intends to develop best-in-class differentiated therapeutics and deliver superior science-driven discovery alliances with pharmaceutical and biotechnology companies. Evotec has long-term discovery alliances with partners including Boehringer Ingelheim, CHDI, Novartis, Ono Pharmaceutical and Roche. The Company has a P2X 7 antagonist for the treatment of inflammatory diseases in clinical development and a series of preclinical compounds and development partnerships, including a strategic alliance with Roche for EVT 101, a subtype selective NMDA receptor antagonist for use in treatment-resistant depression. |
EXCELLA GmbH [ company website ] |
|
 |
Excella GmbH, Germany, is part of the FAREVA group as a leading site in pharmaceutical services. Excella, former Heumann PCS, is located in Bavaria, ca. 100 miles north of Munich at the city border of Nürnberg. Since 20 years Excella is operating in third party business and became a world wide leading expert in handling High Potent molecules as API and for solid dosage forms. State of the art production units in both segments guarantee a safety standard to handle OEL 5 substances. Excella performed to preferred supply status for many prominent global players in the key markets like US, EU and Japan. |
Ferro Corporation [ company website ] |
|
 |
Ferro Pfanstiehl Laboratories, Inc. is based in Waukegan, Illinois and manufactures commercial quantities of specialty and blocked sugars,high-purity low-endotoxin carbohydrates, pharmaceutical intermediates, and high-potency active pharmaceutical ingredients under current good manufacturing (cGMP) conditions and has more than 20 active US and international Drug Master Files. |
Fuji Chemical Industry Co., Ltd. [ company website ] |
|
 |
Fuji Chemical Industry is a pharmaceutical contract manufacturer with cGMP facilities for production of API, spray drying and finished dosage forms. We have particular expertise in spray drying which can be used to improve API properties and develop amorphous solid dispersions for increased drug solubility and bioavailability. We have world-class capabilities developed over decades of experience and offer customized services to support projects from early-stage development through commercial production, including custom formulation services. |
Gelest, Inc. |
|
 |
Gelest Inc. is recognized world-wide as a leader and innovator in materials science and technology. Gelest manufactures and provides organosilicon and metal-organic compounds serving advanced technology markets though a customer driven approach. Please visit www.gelest.com for more information. |
Grace Davison Discovery Sciences [ company website ] |
|
 |
Grace specializes in materials-based, value-added solutions for the pharmaceutical process manufacturing industry. Grace’s Synthetech product line provides contract manufacturing services in organic synthesis, biocatalysis, and chiral technologies. The product offering also includes specialty amino acids, peptide building blocks and fragments, and proprietary custom chiral intermediates primarily for the pharmaceutical, biotech, and cosmeceutical industries. The Synthetech products support the development and manufacture of therapeutic peptides, peptidomimetic, and small molecule drugs at every stage of the clinical development pipeline; including regulatory starting materials, advanced intermediates, and early-phase APIs; from grams to tons. Grace also manufactures Syloid® FP silica, a multi-functional excipient which has unique properties that improve handling, adsorption, dissolution and delivery of pharmaceutical compounds. In addition, Grace offers products for pilot and process scale purification, including Davisil® and Vydac® chromatographic media, MODcol® flanged and Spring® dynamic axial compression preparative and process columns, and Multipacker® column packing stations. With manufacturing sites in Europe, North America, South America and Asia, and experience in regulatory and quality compliance, Grace is well positioned to support the needs of global pharmaceutical companies with local service and expertise. |
GVK BIO [ company website ] |
|
 |
GVK Biosciences is one of India's premier contract research organizations, providing an integrated platform of research services across the pharmaceutical research & development value chain to a growing number of global pharma and biotech companies. GVK BIO combines science, innovation and resources to help clients address their drug discovery and development challenges in the areas of Medicinal & Process Chemistry, Biology, Informatics, Clinical Pharmacology, Clinical Research and KPO. The company aims to become a preferred partner of choice for collaborative research projects. |
Helsinn [ company website ] |
|
 |
Helsinn Chemical Operations develop and manufacture APIs, cGMP Advanced Intermediates and High Potency Active Ingredients (HPAIs) for third parties from early phases to commercial supply on an exclusive basis. The production plants are located in Switzerland and Ireland, with the Swiss plants successfully inspected by the FDA (with no 483 observations). Scale is from few hundreds of grams (HPAIs), up to tens of tons for APIs in plants fully dedicated to cGMP manufacturing. Long-term experience in management of the CMC part and full regulatory support is available for our partners. Helsinn’s expertise along with our reputation with the Authorities will speed-up the registration of our partner’s NCE. |
Hengdian Group [ company website ] |
|
 |
Hengdian Group was established in 1975 and is now a multinational company and one of the largest privately owned companies in China. The Pharmaceutical and Chemical division has three factories and over 3500 employees, with 2 of them having passed an FDA audit. Our products include intermediates, API’s as well as other speciality chemicals. We have worked with many multinational companies in contract manufacturing for over 10 years. We aim to be efficient, flexible, and fast, offering the best service and quality to our customers. |
Hybio [ company website ] |
|
 |
Hybio is a hi-tech enterprise specialized in the R&D and manufacturing of diverse peptide products. Founded in 1998, after over decades of effort, we have grown to be one of the largest and most professional peptide pharmaceutical company in China. We were one of the first to enter the peptide pharmaceutical industry in China, and we are the only one that has a full range of peptide products and services, including peptide finished dosage products, peptide API products, and peptide CRO&CMO services. Our peptide finished dosage is mainly sold in the domestic market, but some of our peptide APIs have been supplied to customers all over the world. Hybio is a GMP-approved pharmaceutical company. Our GMP plant in Shenzhen is a facility occupying an area of more than 1,5000 sq.m. It has been often audited and inspected by local/national s-FDA authorities and by clients all over the world. |
IRIX Pharmaceuticals [ company website ] |
|
 |
IRIX Pharmaceuticals is a recognized CRO/CMO specializing in Small Molecule APIs and Advanced Intermediates. IRIX has the expertise and experience to solve very complex chemistry challenges while meeting aggressive clinical delivery timelines. IRIX has High Containment, High Pressure, Cryogenic, Beta-Lactam and Controlled Substances capabilities. We have two US facilities both of which have been successfully inspected by the FDA along with additional laboratory facilities in St. Petersburg, Russia. |
ISOCHEM [ company website ] |
|
 |
ISOCHEM manufactures products and offers services that meet the most recent and stringent regulatory standards of the Pharmaceutical industry. We implement complex reactions and technologies, while mastering the risk to produce the highest quality products in full compliance with EHS and International Standards of Quality. |
J-Star Research [ company website ] |
|
 |
J-STAR Research, J-STAR, based in South Plainfield, NJ is capable of tackling some of the most challenging chemistry problems in the industry including developing optimal synthetic routes, process research, scale up, synthesis of metabolites and impurities, developing novel synthetic strategies and cGMP manufacturing. The company was founded by a Dr. Andrew Thomson from Merck over ten years ago. |
Johnson Matthey [ company website ] |
|
 |
Johnson Matthey Pharma Services (JMPS) provides development and manufacturing services for active pharmaceutical ingredients (APIs). Located ~35 miles west of the Boston/Cambridge area, our recently built facility (2001) offers a design that incorporates both kilo-labs and pilot plant with expansion opportunity. Services provided at JMPS are crucial for development and manufacturing needs of new chemical entities (NCEs) bound for clinical trials and market-approval (commercial use). Strong cGMP and regulatory compliance underscores our services for custom synthesis, process development, scale-up, optimization, validation, and medicinal chemistry. Beyond traditional chemistry services, we can provide solutions for complex molecules by leveraging technologies within our site and the Johnson Matthey group. These technologies include separation technologies (SMB, chiral separations, prep HPLC, diafiltration, etc.), asymmetric/chiral development and analytical technologies, and catalysts (process). Our services are retained for a variety of compounds including small molecules, natural products (extraction), controlled drug substances, and highly potent active ingredients (HPAI). We are able to offer a wide range of manufacturing scale from grams to hundreds of kilograms. To round out these services, our regulatory department has an impeccable track record with FDA compliance audits, and provides CMC, IND, and NDA support to our client’s regulatory filings. |
Julabo USA [ company website ] |
|
 |
The Temperature Control Company, offers a wide selection of liquid temperature control equipment including: Water Baths, Recirculating Chillers, Immersion Coolers, Calibration & Visco Baths, Heating and Refrigerated Circulators, and the new Presto Plus Highly Dynamic Temperature Control Systems providing up to 36 kW of heating power and 30 kW of cooling power. All JULABO products carry a 2-year warranty. North American customers are supported from JULABO USA facilities in Allentown, PA and Vista, CA. Our JULABO certified service department also provides planned maintenance, IQ/OQ, installation/training and service plans. |
Lonza [ company website ] |
|
 |
Lonza offers the life sciences market a full range of products, flexible development services and high-quality manufacturing for functional and active ingredients. For 30 years Lonza Custom Manufacturing has been helping emerging and established companies increase product quality, improve production processes, navigate the development and regulatory process, lower the cost of goods, get to market faster, and focus on their core competencies. From lead optimization and early development through launch to commercial leadership and mature market supply, our complete development services, industry-leading manufacturing processes, broad technology platform and lifecycle management experience can help take your product to the next level. For flexible, high-quality contract manufacturing, development services and products, we can help. Together … turning promising discoveries into viable products. |
Mercachem [ company website ] |
|
 |
Mercachem is a privately owned leading European contract research organization offering innovative exploratory chemistry, medicinal chemistry and process R&D services to accelerate the drug discovery and development process in a flexible and cost-effective way. Mercachem was founded in 1997, occupies 3,500 m2 state-of-the-art research facilities in Nijmegen, the Netherlands, and employs more than 100 chemists. Working for many pharmaceutical and biotech companies throughout the world, Mercachem is recognized for its high-quality products and services and its unprecedented problem solving capabilities.
Medicinal chemistry
Process Research
|
Micron Technologies Inc [ company website ] |
|
 |
Micron Technologies provides contract particle size reduction and analytical services for the pharmaceutical and biotech industries. We offer micronization, mechanical milling, and classification in isolated processing suites. Our analytical laboratory offers material characterization testing, including but not limited to, particle size, TGA, DVS, XRPD, DSC, stability, method development and validation. US and UK facilities are FDA inspected. |
MP Biomedicals [ company website ] |
|
 |
MP Biomedicals is a worldwide corporation with ISO-certified and FDA-approved manufacturing and distribution facilities throughout the world. The company manufactures and sells more than 55,000 products and is one of the only companies in the industry to offer a comprehensive line of Life Science, Fine Chemical and Diagnostic products. MP Biomedicals is dedicated to providing innovative, quality tools and superior service to aid researchers in their quest for groundbreaking discovery. |
Navin Fluorine International Ltd. [ company website ] |
|
 |
Navin Fluorine International Ltd. (NFIL, >40 years, >US$98M, public company in India) has extensive expertise in specialty fluorine chemistry and fluorination services. NFIL invested to grow our offerings with a state-of-the-art R&D center (2008 and Dec 2010), pilot plant (2009), new multi-product plant (July 2010), cGMP pilot plant (Feb 2011), and full cGMP production facility (late 2011). NFIL launched its Contract Research division for full CRAMS (Contract Research and Manufacturing Service) support. We can synthesize individual compounds, libraries, or scaffolds, and also efficiently develop processes from lab, to pilot, to commercial. FluorosimilarsT services offer fluorine analogs of desired targets. NFIL provides custom synthesis and toll manufacturing from mg/g to full multi-ton commercial scales (plus commercial fluorination reagents, intermediates, etc.) via almost all fluorination methods including HF, Halex, electrochemistry, and even a proprietary alternative to DAST, just to name a few. For more information contact Jeffery S. Hinkle, Ph.D., MBA, Global Head of Business Development, 732-377-3362, Cell: 908-304-3562, or jeffery.hinkle@nfil.in. |
Nissan Chemical Industries [ company website ] |
|
 |
Nissan Chemical Industries provides custom manufacturing and process development services for APIs and their intermediates from pre-clinical to commercial production stages. In addition, we offer analytical method development, stability testing, and filing of DMFs. Our company has various technologies for asymmetric synthesis, such as epoxidation, anti-selective hydrogenation, aldol reaction, and Michael reaction, for manufacturing optically active substances. We also have been working on AZADO, an ultra-highly active catalyst for alcohol oxidation, for commercial development. |
NovAliX [ company website ] |
|
 |
NovAliX is focusing on the development of enabling chemistry and biophysical technologies to support the pharmaceutical industry’s outsourcing needs from discovery to manufacturing. With proprietary unique SPR technology, X-ray protein crystallography, supramolecular mass spectrometry and chemistry NovAliX offers comprehensive integrated services for small molecule drug discovery. With advanced NMR technologies, NovAliX provides fine characterization of biologics, thorough analysis of APIs and polymorphism studies to support pharmaceutical development and manufacturing teams. NovAliX Group, a team of 120 scientists, is located in state-of-the-art laboratory facilities in Strasbourg-Illkirch (France) and Heidelberg (Germany). |
Novasep [ company website ] |
|
 |
Novasep develops, markets and operates innovative technologies to produce synthetic molecules from lab to industrial scale. Our applications cover the pharmaceutical, agrochemical and fine chemical markets. We offer contract synthesis and purification in 6 FDA-inspected facilities for early development, clinical and commercial scale (up to several hundreds of tons), with full regulatory support.
Our process development teams select, develop and optimize synthetic and purification routes to provide you with cost-effective solutions in the minimum amount of time. Novasep combines conventional chemistry with special technologies:
Our offering includes designing your process, as well as engineering, building, validating and operating manufacturing plants for your synthetic APIs.
|
PCAS-Nanosyn [ company website ] |
|
 |
PCAS and Nanosyn are pleased to introduce their joint venture, PCAS-Nanosyn LLC. The JV is designed to bridge the capabilities of the two parent companies to offer our customers a seamless transition for custom chemical services from discovery chemistry at Nanosyn through to commercial scale API and fine chemical production at PCAS. The primary site of the JV is the cGMP kilolab asset and staff, formerly known as Seres Laboratories, and its 30 year experience base as a FDA registered site. With six, separate cGMP suites, including two, certified Class 10,000 clean rooms, the PCAS-Nanosyn site combines small company personal service and flexibility with large company derived expertise for process identification, development, scale-up, and manufacture under cGMP protocols. Please stop by our booth and share our excitement in this new venture, and visit our websites for more information at www.pcas-nanosyn.com; www.pcas.fr.com; and www.nanosyn.com. |
Peakdale Molecular [ company website ] |
|
 |
Peakdale Molecular offers a class-leading range of products and services to its pharmaceutical and biotechnology customers to accelerate their drug discovery initiatives. At its very core, Peakdale’s approach is based upon its long & successful track record of problem-solving within our customers’ discovery projects. We are renowned for completing difficult synthetic organic and medicinal chemistry against time & cost constraints for customers big and small the world over. This we do through a huge variety of FTE or Fee-for-Service models. Whether it is process development , small molecule discovery programme that needs computational, chemistry & ADME services or “design & make” projects for scaffolds & synthons, Peakdale offers flexible, creative and confidential support for your discovery project. |
Pharmaceutical Outsourcing [ company website ] |
|
 |
Pharmaceutical Outsourcing is a bi-monthly the journal dedicated to pharmaceutical and biopharmaceutical contract services. With regular sections on clinical trials, contract research, preclinical development, , formulation/development services, contract analytical testing, APIs, stability testing, clinical research and contract manufacturing., we bring the most complete coverage of trends and issues in the industry. Our magazine is 100% direct request and has the highest percentage of "one-year" qualified subscribers in the industry. Our editorial is written only by pharma, biotech, non-profit organization and the FDA to insure that all articles are without bias and non-promotional. |
PharmaCore, Inc. [ company website ] |
|
 |
Since 2000, PharmaCore® has performed a variety of chemistry services for leading pharmaceutical and biotechnology companies including: custom organic synthesis; cGMP scale-up; development of novel molecular building blocks; chemical process research and development; and medicinal chemistry services. Our success is due to our competitive pricing, our unwavering commitment to customer service and to the talent and experience of our scientists, most of whom hold doctorates in organic chemistry. |
PharmaZell [ company website ] |
|
 |
PharmaZell offers to its clients standard and custom made APIs and intermediates as well as all chemical, pharmaceutical development services and regulatory activities required to bring a pharmaceutical product to the market. PharmaZell develops innovative processes for APIs and Intermediates through its R&D groups that cover all scales from laboratory to commercial production. Through the acquisition of GEA, PharmaZell provides fully vertically integrated development programmes from API to finished dosage form including regulatory documentation, procedures and strategies. |
Piramal Healthcare [ company website ] |
|
 |
Pharma Solutions is the Contract Development and Manufacturing division of Piramal Healthcare (erstwhile known as Nicholas Piramal) Pharma Solutions is one of the very few Contract Manufacturing Organizations (CMOs) that can provide end-to-end support for bringing a drug to market or managing the life cycle of a launched drug. We offer Clinical Phase API synthesis and Formulations Development services and scale up to Commercial API and Finished Dosage form supply. |
Ricerca Biosciences [ company website ] |
|
 |
Ricerca is the only North American CRO to offer the unique IP-INDSM concept to pharmaceutical and biotechnology companies. The site encompasses all discovery and development services required to bring a target or drug candidate to a complete IND submission. The ability to perform both chemistry (medicinal chemistry, process chemistry, cGMP API kilo-lab and pilot plant production, complete analytical) and biology (DMPK, ADME, full toxicology, safety pharmacology, animal efficacy models, bioanalytical) as well as report writing and regulatory services at one site makes Ricerca the provider of choice for virtual, small, and medium-sized pharmaceutical companies seeking a successful IND submission. |
Rohnerchem [ company website ] |
|
 |
RohnerChem is a Swiss custom manufacturer specializing in organic syntheses of complex molecules. Our core technologies include transition metal catalysis, high-pressure hydrogenations, carbonylations, low-temperature reactions, hydrazine handling and polymerisations. Custom manufacturing with RohnerChem means technology transfer, process optimization, scale-up, piloting and large-scale production of your intermediate or active based on a broad tool box of capabilities and technologies. All laboratory and large scale manufacturing is carried out according to ISO up to cGMP standards. For additional information, please visit our website at http://www.rohnerchem.com or contact us by e-mail: info@rohnerchem.com . |
Saltigo [ company website ] |
|
 |
Saltigo offers you a comprehensive set of services ranging from route selection, synthesis and process development, full analytical services, manufacturing at small scale under CGMP and ISO, regulatory expertise/support, and professional project management. |
Sarmont [ company website ] |
|
 |
SARmont is a trusted provider of medicinal chemistry design and lead optimization services. Our scientific team is led by Dr. John Talley, the inventor of Celebrex and seven other drugs that successfully reached the market. Our team works collaboratively with clients to identify and optimize proprietary investigational new drug (IND) candidates. We use a combination of rational drug design, insightful activity trend analysis, informed interpretation of medical need, and careful synthetic planning. To assure cost efficient compound synthesis we utilize a respected high quality strategic CRO partner in India, Escientia. All IP is retained by our clients – we streamline and accelerate your drug design process, through effective project management of the design, synthesis and lead optimization process. |
Scynexis [ company website ] |
|
 |
SCYNEXIS delivers integrated, efficient and innovative drug discovery and development solutions to our global health and pharmaceutical partners. Our record of success is exemplified by the delivery of 11 pre-clinical drug candidates over the last five years. Milestone payments have resulted as these compounds progressed through development at our partners. Our fully-integrated contract research solutions include medicinal chemistry, advanced biological screening, in vitro pharmacology and ADMET, DMPK, bioanalytical and analytical chemistry, process chemistry, and cGMP manufacturing. The SCYNEXIS process chemistry department recently passed a general inspection and pre-approval inspection (PAI) by the FDA in support of a customer’s NDA. Our expertise is offered on a fee for service basis or may be conducted in a shared risk arrangement. SCYNEXIS’ teams are tailored to be especially effective in moving customer projects from concept to clinic, utilizing powerful proprietary technologies such as the HEOS® Data Management and Collaboration Software Suite and the MEDCHEM-FACTORY® High-Throughput Synthesis and Purification Platform. Founded in 2000, SCYNEXIS is located in Research Triangle Park, N.C. SCYNEXIS is registered with both the FDA and DEA. |
Sentinel Process Systems [ company website ] |
|
 |
KiloLabs.com division of Sentinel Process Systems, Inc. designs and builds systems for API Production, Kilo Labs, and Pilot Plants. Our equipment is used extensively for organic synthesis and scale up of pharmaceutical intermediates and potent compounds. We also proudly represent other specialty process equipment manufacturers like Aurora Filters who fabricate Contained Glove Box Filters, GL Filtration who manufacturers High Containment Filter Dryers and Steroglass who design Industrial Scale Rotary Evaporators. Our dedicated team of engineers will gladly assist you in selecting the ideal equipment and systems for your FDA/GMP facility. Sentinel - delivering quality and technology, it's our job. |
Shanghai Chemspec Corporation [ company website ] |
|
 |
Shanghai Chemspec Corporation, a recent NYSE-listed Chinese company, is a leading manufacturer of high-quality specialty and fine chemicals. In particular, we are the largest manufacturer of fluorinated organic chemicals in China based on sales. With research and development expertise, we have been offering high quality manufacturing services for pharmaceutical, agrochemical, and electronics industries. With headquarter in Shanghai and four manufacturing facilities in surrounding area; we are able to produce a broad range of chemicals scaling from kilograms to tens of metric tons to support all stages of pharmaceutical product life-cycle management with competitive pricing and environmentally-friendly operations. |
Siegfried USA [ company website ] |
|
 |
Siegfried is a globally active, independent Swiss company. As a supplier and service provider for the worldwide pharmaceutical industry, we concentrate on the development and production of pharmaceutical drug substances and customer-manufactured finished drugs, and offer all related services. We focus on maintaining the highest level of competence, working together with our clients as partners. Our specific know-how in process development, chemical and pharmaceutical production, and managing complex outsourcing projects is used to contribute significantly to the success of our customers. |
Solid Form Solutions [ company website ] |
|
 |
Solid Form Solutions is a world leading contract research organization (CRO) providing the pharmaceutical industry with polymorph, salt and co-crystallisation screening services. Our services also include crystallisation development, particle development as well as basic physical properties / developability characterisation. Our aim is to be flexible, understand our client’s solid form problems and recommend workable solutions. Whether our expertise is required to deliver a solid form screening program or tackle specific problems encountered during drug manufacture, Solid Form Solutions will provide an unrivalled service. |
Solvias [ company website ] |
|
 |
Solvias is a privately held company located in Basel/Switzerland. With over 300 highly qualified employees, Solvias supports the research and development of new drug substances and the optimization of manufacturing processes for pharmaceutical, biotechnology and life science companies worldwide. Customers benefit from a wide range of experience in the following areas: Chemical Development and cGMP Manufacturing , Catalysis, Analytical Services, Process analytical technologies and, Polymorphism, salts and crystallization. All analytical services are cGMP-approved by the FDA and Swiss authorities. |
SST Corporation/Fermion [ company website ] |
|
 |
SST is a full-service pharmaceutical agency that represents world-class manufacturers of active pharmaceutical ingredients (APIs) and fine chemicals and intermediates (FCIs). Our audited network of global suppliers provide gram to commercial-scale production of APIs and FCIs, as well as custom synthesis. We bring substantial added value to this service with in-depth regulatory and technical expertise and processing, supply-chain management and other services. |
Syncom B.V. [ company website ] |
|
 |
Syncom is a privately owned company established in 1988. It has grown rapidly in recent years and currently employs 130 chemists 75 of whom have PhD degrees and the rest a masters degree or equivalent. About 95% of the work carried out is for the pharmaceutical industry and the other 5% is devoted to the synthesis of organic materials. The company is involved in Medicinal chemistry and drug discovery and synthetic support for chemical development and process research. The major focus is on synthesis for discovery chemistry support. Syncom is located in the Groningen in The Netherlands. Our business is with big farma companies, medium sized and biotech companies form Europe and the US. |
SynQuest/Central Glass Germany [ company website ] |
|
 |
SynQuest Laboratories and Central Glass Germany are wholly owned subsidiaries of Central Glass Company (Japan). SynQuest is a technology based manufacturer specializing in fluorine compounds. Services include custom synthesis, contract manufacturing, bulk intermediates. It also markets a research catalog containing a wide range of gases, aliphatic and aromatic fluorine compounds, including building blocks, chiral chemicals, mass spectrometry markers, etc. |
Syntagon AB |
|
 |
Syntagon is a leading Scandinavian-based drug development partner. With two sites: in Södertälje, Sweden and Riga, Latvia we can develop your compound and provide a full regulatory package from Lead Optimisation through to Phase III clinical trials. Core competencies include; GMP manufacture, solid-state development (with a 98% crystallization success rate), manufacture and analysis of cytotoxic APIs and low cost Latvia for development work. Syntagon is the only CRO in the world that guarantees CMC approval. We’re Smaller. We’re Faster. We try Harder. To find out what Syntagon can do for you, make an appointment with our CMC experts during Chemoutsourcing by suggesting a time and emailing info@syntagon.com.
. |
Ubichem, Inc. [ company website ] |
|
 |
Ubichem provides a comprehensive range of chemistry services (on lab to pilot plant scale) to support early pharmaceutical development including cGMP API and intermediate manufacture, process research and development, analytical method development and validation, and radiolabelling. Our expertise helps to minimise the risks associated with the scale-up of medicinal chemistry routes. Reliability and excellent problem-solving skills mean Ubichem is a preferred partner for many pharmaceutical and biotech companies. |
Umicore [ company website ] |
|
 |
Umicore Precious Metals Chemistry is a leading expert in the field of precious metals based specialty chemicals, delivering innovative products and dedicated services to clients around the world. Umicore PMC's highly pure and active precious metals catalysts and chemicals are used in various industries. Besides our range of inorganic chemicals we have developed a wide range of organometallic precious metal catalysts and pre-cursors, which are used primarily for homogeneous catalysis applications.
Our products can be supplied from gram to multi-kilo / bulk quantities. We have considerable expertise in rapid scale up of organometallic precious metal compounds. We are also able to customise catalysts to produce novel metal/ligand combinations for specific projects. We are able to undertake specific research and development projects in conjunction with our customers. Our Applied Technology team are always available to discuss catalyst selection, application, and optimisation, and would be pleased to discuss new requirements and catalysts with you. We operate a strict policy of confidentiality with our customers, which we support with appropriate agreements. |
WC Heraeus [ company website ] |
|
 |
Heraeus has more than 25 years experience in the development and production of high potency oncology APIs. Today, Heraeus offers a unique variety of technical expertise in its state-of-the-art facilities, from chemistry to fermentation processes. Regular inspections by the U.S. FDA as well as other authorities support Heraeus’ main objective of delivering high quality Contract Development and Manufacturing services.
Heraeus is a globally active precious metal and technology Group based in Hanau, near Frankfurt, and with deep roots in Germany. The company has been family-owned for 160 years. In 2010, on the strength of more than 12,900 employees in more than 120 companies, Heraeus generated product revenues of €4.1 billion and precious metals trading revenue of €17.9 billion. |